Basics Oric Pharmaceuticals, Inc. IPO Date: April 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.22B Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 3.64% Avg Daily Range (30 D): $0.40 | 3.28% Avg Daily Range (90 D): $0.31 | 2.79% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): 1.24M Avg Daily Volume (90 D): .88M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 72 Institutional Trades Total Inst.Trades: 877 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $1.79M Avg Inst. Trade (90 D): $2.17M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.73M Avg Closing Trade (30 D): $2.61M Avg Closing Trade (90 D): $1.74M Avg Closing Volume: 144.98K     News Jun 6, 2025 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Feb 7, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Jan 3, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants ... Source: Oric Pharmaceuticals, Inc. Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.47 $-.42 $-.51 Diluted EPS $-.47 $-.42 $-.51 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -36.36M $ -30.02M $ -36.31M Operating Income / Loss $ -39.06M $ -32.72M $ -39.57M Cost of Revenue $ $ $ Net Cash Flow $ 26.53M $ -10.07M $ 15.18M PE Ratio